Omri Gottesman

21.6k total citations
23 papers, 1.6k citations indexed

About

Omri Gottesman is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Omri Gottesman has authored 23 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Omri Gottesman's work include Pharmacogenetics and Drug Metabolism (6 papers), Genetic Associations and Epidemiology (5 papers) and Genomics and Rare Diseases (3 papers). Omri Gottesman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Genetic Associations and Epidemiology (5 papers) and Genomics and Rare Diseases (3 papers). Omri Gottesman collaborates with scholars based in United States, Germany and Nigeria. Omri Gottesman's co-authors include Erwin P. Böttinger, Stephen B. Ellis, Li Li, Rong Chen, Ronald Tamler, Benjamin S. Glicksberg, Wei‐Yi Cheng, Joel T. Dudley, Stuart A. Scott and Girish N. Nadkarni and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Omri Gottesman

23 papers receiving 1.6k citations

Peers

Countries citing papers authored by Omri Gottesman

Since Specialization

Citations

This map shows the geographic impact of Omri Gottesman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omri Gottesman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omri Gottesman more than expected).

Fields of papers citing papers by Omri Gottesman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omri Gottesman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omri Gottesman. The network helps show where Omri Gottesman may publish in the future.

Co-authorship network of co-authors of Omri Gottesman

This figure shows the co-authorship network connecting the top 25 collaborators of Omri Gottesman. A scholar is included among the top collaborators of Omri Gottesman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omri Gottesman. Omri Gottesman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prescriber Adoption of SLCO1B1Genotype‐Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program 2022 ·Clinical Pharmacology & Therapeutics ·Aniwaa Owusu Obeng, Stuart A. Scott, (unknown), Stephen B. Ellis, (unknown), (unknown), Rajiv Nadukuru, Noura S. Abul‐Husn, Aida Vega, Eva Waite, Omri Gottesman, Judy H. Cho, Erwin P. Böttinger	4
2	Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn’s Disease 2021 ·Scientific Reports ·Julie Horowitz, Neil Warner, Jeffrey Staples, Eileen Crowley, Nehal Gosalia, Ryan Murchie, Cristopher V. Van Hout, Karoline Fiedler, (unknown), Alejandra King, Jeffrey G. Reid, John D. Overton, Aris Baras, Alan R. Shuldiner, Anne M. Griffiths, Omri Gottesman, Aleixo M. Muise, Claudia Gonzaga‐Jauregui	46
3	Rapid response to the alpha-1 adrenergic agent phenylephrine in the perioperative period is impacted by genomics and ancestry 2020 ·The Pharmacogenomics Journal ·Stéphane Wenric, Janina M. Jeff, Thomas T. Joseph, Muh‐Ching Yee, Gillian M. Belbin, Aniwaa Owusu Obeng, Stephen B. Ellis, Erwin P. Böttinger, Omri Gottesman, Matthew A. Levin, Eimear E. Kenny	1
4	Clinical and Molecular Prevalence of Lipodystrophy in an Unascertained Large Clinical Care Cohort 2019 ·Diabetes ·Claudia Gonzaga‐Jauregui, Wenzhen Ge, Jeffrey Staples, Cristopher V. Van Hout, Ashish Yadav, (unknown), Joseph B. Leader, H. Lester Kirchner, Michael F. Murray, Jeffrey G. Reid, David J. Carey, John D. Overton, Alan R. Shuldiner, Omri Gottesman, (unknown), Jesper Gromada, Aris Baras, Judith Y. Altarejos	55
5	Identification of unique venous thromboembolism-susceptibility variants in African-Americans 2017 ·Thrombosis and Haemostasis ·Sebastian M. Armasu, Bryan M. McCauley, Iftikhar Kullo, Hugues Sicotte, Jyotishman Pathak, Christopher G. Chute, Omri Gottesman, Erwin P. Böttinger, Joshua C. Denny, (unknown), (unknown), (unknown), Mariza de Andrade, John A. Heit	24
6	Implementing Algorithm‐Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing 2016 ·Clinical Pharmacology & Therapeutics ·Aniwaa Owusu Obeng, (unknown), (unknown), Omri Gottesman, (unknown), Eva Waite, Kristin M. Myers, (unknown), (unknown), (unknown), Stuart A. Scott	8
7	PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability 2016 ·Journal of the American Medical Informatics Association ·Jacqueline Kirby, Peter Speltz, Luke V. Rasmussen, Melissa Basford, Omri Gottesman, Peggy Peissig, Jennifer A. Pacheco, Gerard Tromp, Jyotishman Pathak, David Carrell, Stephen B. Ellis, Todd Lingren, (unknown), Guergana Savova, Jonathan L. Haines, Dan M. Roden, Paul A. Harris, Joshua C. Denny	238
8	Identification of type 2 diabetes subgroups through topological analysis of patient similarity 2015 ·Science Translational Medicine ·Li Li, Wei‐Yi Cheng, Benjamin S. Glicksberg, Omri Gottesman, Ronald Tamler, Rong Chen, Erwin P. Böttinger, Joel T. Dudley	335
9	Incorporating temporal EHR data in predictive models for risk stratification of renal function deterioration 2014 ·Journal of Biomedical Informatics ·Anima Singh, Girish N. Nadkarni, Omri Gottesman, Stephen B. Ellis, Erwin P. Böttinger, John V. Guttag	101
10	Effect of Genetic African Ancestry on eGFR and Kidney Disease 2014 ·Journal of the American Society of Nephrology ·Miriam S. Udler, Girish N. Nadkarni, Gillian M. Belbin, Vaneet Lotay, Christina Wyatt, Omri Gottesman, Erwin P. Böttinger, Eimear E. Kenny, Inga Peter	61
11	Development and validation of an electronic phenotyping algorithm for chronic kidney disease. 2014 ·PubMed ·Girish N. Nadkarni, Omri Gottesman, James G. Linneman, Herbert Chase, Richard L. Berg, Samira Farouk, Rajiv Nadukuru, Vaneet Lotay, Ian O. Ellis, George Hripcsak, Peggy Peissig, Chunhua Weng, Erwin P. Böttinger	36
12	Implementation and utilization of genetic testing in personalized medicine 2014 ·Pharmacogenomics and Personalized Medicine ·Stuart A. Scott, Noura S. Abul‐Husn, Aniwaa Owusu Obeng, Saskia C. Sanderson, Omri Gottesman	69
13	A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury 2013 ·Journal of the American Medical Informatics Association ·Casey Lynnette Overby, Jyotishman Pathak, Omri Gottesman, Krystl Haerian, Rimma Perotte, Seán Murphy, (unknown), (unknown), Jayant A. Talwalkar, Yufeng Shen, Ian O. Ellis, Iftikhar J. Kullo, Christopher G. Chute, Carol Friedman, Erwin P. Böttinger, George Hripcsak, Chunhua Weng	51
14	Genetic polymorphisms associated with intervertebral disc degeneration 2013 ·The Spine Journal ·Jillian Mayer, James C. Iatridis, Danny Chan, Sheeraz A. Qureshi, Omri Gottesman, Andrew C. Hecht	160
15	The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics–Pharmacogenomics 2013 ·Clinical Pharmacology & Therapeutics ·Omri Gottesman, Stuart A. Scott, Stephen B. Ellis, Casey Lynnette Overby, (unknown), Jean‐Sébastien Hulot, Jennifer L. Hall, (unknown), (unknown), Joseph Kannry, Erwin P. Böttinger	115
16	Opportunities for genomic clinical decision support interventions 2013 ·Genetics in Medicine ·Casey Lynnette Overby, Isaac S. Kohane, Joseph Kannry, Marc S. Williams, Justin Starren, Erwin P. Böttinger, Omri Gottesman, Joshua C. Denny, Chunhua Weng, Peter Tarczy‐Hornoch, George Hripcsak	53
17	Systems Pharmacology of Adverse Event Mitigation by Drug Combinations 2013 ·Science Translational Medicine ·Shan Zhao, Tomohiro Nishimura, Yibang Chen, Evren U. Azeloglu, Omri Gottesman, Chiara Giannarelli, M. Urooj Zafar, Ludovic Bénard, Juan J. Badimón, Roger J. Hajjar, Joseph Goldfarb, Ravi Iyengar	98
18	Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians 2012 ·International Urology and Nephrology ·Bamidele O. Tayo, Holly Kramer, Babatunde Salako, Omri Gottesman, (unknown), Adesola Ogunniyi, Erwin P. Böttinger, Stephen S. Rich	45
19	Can Genetic Pleiotropy Replicate Common Clinical Constellations of Cardiovascular Disease and Risk? 2012 ·PLoS ONE ·Omri Gottesman, Esther Drill, Vaneet Lotay, Erwin P. Böttinger, Inga Peter	21
20	Genetic Background of Patients from a University Medical Center in Manhattan: Implications for Personalized Medicine 2011 ·PLoS ONE ·Bamidele O. Tayo, Marie Teil, Liping Tong, Huaizhen Qin, Gregory Khitrov, Weijia Zhang, (unknown), Omri Gottesman, Xiaofeng Zhu, Alexandre C. Pereira, Stephen S. Rich, Erwin P. Böttinger	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact